OIM
Oracle Investment Management Portfolio holdings
AUM
$116M
This Quarter Return
+11.41%
1 Year Return
+84.31%
3 Year Return
+539.5%
5 Year Return
+791.07%
10 Year Return
+13,222.09%
AUM
$796M
AUM Growth
+$796M
(+11%)
Cap. Flow
+$50.9M
Cap. Flow
% of AUM
6.4%
Top 10 Holdings %
Top 10 Hldgs %
88.61%
Holding
34
New
5
Increased
9
Reduced
5
Closed
2
Top Buys
| 1 |
Vir Biotechnology
VIR
|
$20.7M |
| 2 |
Atea Pharmaceuticals
AVIR
|
$10.8M |
| 3 |
QuidelOrtho
QDEL
|
$9.82M |
| 4 |
Guardant Health
GH
|
$8.75M |
| 5 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$5.76M |
Top Sells
| 1 |
SPDR S&P Biotech ETF
XBI
|
$10.3M |
| 2 |
Capricor Therapeutics
CAPR
|
$5.98M |
| 3 |
DMTK
DermTech, Inc. Common Stock
DMTK
|
$1.4M |
| 4 |
MOTS
Motus GI Holdings, Inc. Common Stock
MOTS
|
$517K |
| 5 |
Biodesix
BDSX
|
$449K |
Sector Composition
| 1 | Healthcare | 99.94% |
| 2 | Energy | 0.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Biogen
BIIB
$20.5B
| $683K | 0.09% |
2,412
| – | – |
|
|
VTNR
27
DELISTED
Vertex Energy, Inc
VTNR
| $472K | 0.06% |
90,000
| – | – |
|
28
XBiotech
XBIT
$92.1M
| $275K | 0.03% |
+350,000
| New | +$275K |
|
|
29
Capricor Therapeutics
CAPR
$289M
| – | – |
-1,166,249
| Closed | -$5.98M |
|
30
Eli Lilly
LLY
$659B
| – | – |
0
| – | – |
|
31
Pfizer
PFE
$142B
| – | – |
0
| – | – |
|
32
Invesco QQQ Trust
QQQ
$361B
| – | – |
0
| – | – |
|
33
SPDR S&P 500 ETF Trust
SPY
$653B
| – | – |
0
| – | – |
|
|
34
SPDR S&P Biotech ETF
XBI
$5.25B
| – | – |
-76,200
| Closed | -$10.3M |
|